Current challenges and opportunities in treating hypoxic prostate tumors

Declan McKenna, Rachel Errington, Klaus Pors

Research output: Contribution to journalArticle

LanguageEnglish
Pages11
JournalJournal of Cancer Metastasis and Treatment
Volume4
Issue number3
Publication statusPublished - 1 Mar 2018

Keywords

  • Hypoxia
  • prostate cancer
  • hypoxia activated prodrugs
  • OCT1002
  • AQ4N
  • bioinformatics
  • DNA damage
  • combination therapies

Cite this

@article{c4616faf44084398b5020517a1904bde,
title = "Current challenges and opportunities in treating hypoxic prostate tumors",
keywords = "Hypoxia, prostate cancer, hypoxia activated prodrugs, OCT1002, AQ4N, bioinformatics, DNA damage, combination therapies",
author = "Declan McKenna and Rachel Errington and Klaus Pors",
year = "2018",
month = "3",
day = "1",
language = "English",
volume = "4",
pages = "11",
journal = "Journal of Cancer Metastasis and Treatment",
issn = "2394-4722",
number = "3",

}

Current challenges and opportunities in treating hypoxic prostate tumors. / McKenna, Declan; Errington, Rachel; Pors, Klaus.

In: Journal of Cancer Metastasis and Treatment, Vol. 4, No. 3, 01.03.2018, p. 11.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Current challenges and opportunities in treating hypoxic prostate tumors

AU - McKenna, Declan

AU - Errington, Rachel

AU - Pors, Klaus

PY - 2018/3/1

Y1 - 2018/3/1

KW - Hypoxia

KW - prostate cancer

KW - hypoxia activated prodrugs

KW - OCT1002

KW - AQ4N

KW - bioinformatics

KW - DNA damage

KW - combination therapies

M3 - Article

VL - 4

SP - 11

JO - Journal of Cancer Metastasis and Treatment

T2 - Journal of Cancer Metastasis and Treatment

JF - Journal of Cancer Metastasis and Treatment

SN - 2394-4722

IS - 3

ER -